The Impact of COVID-19 on Maternal Death and Fetal Death, a Cohort Study in Brazil
Overview
Authors
Affiliations
Objective: The study aimed to evaluate the risk of maternal death and fetal death among pregnant women infected with SARS-CoV-2.
Methods: This is a retrospective cohort study among pregnant women with secondary data from the National Live Births System (Sistema Nacional de Nascidos Vivos), National Mortality System (Sistema Nacional de Mortalidade), and e-SUS Health Surveillance System (Sistema e-SUS Vigilância em Saúde). Pregnant women confirmed for COVID-19 had positive RT-PCR between March 2020 and May 2021, pregnant women without COVID-19 were those without notification for disease. Maternal death, fetal death, and stillbirth were assessed as primary outcomes.
Results: We included 68,673 pregnant women not notified as suspected of COVID-19 and 1,386 with a confirmed diagnosis of COVID-19. Among pregnant women with COVID-19, 1013 (73.0%) were aged 20 to 34 years, 655 (47.2%) were brown, 907 (65.4%) had ≥ 8 years of education, in the third trimester of pregnancy (41.5%), undergoing cesarean section (64.5%). In adjusted analyses, COVID-19 in pregnancy had a higher risk of maternal death (relative risk [RR] 18.73-95% confidence interval [95%CI] 11.07-31.69), fetal death/stillbirth (RR 1.96-95%CI 1.18-3.25), preterm birth [RR 1.18-95%CI 1.01-1.39], cesarean delivery (RR 1.07-95%CI 1.02-1.11), and cesarean delivery occurring before the onset of labor (RR 1.33-95%CI 1.23-1.44).
Conclusion: COVID-19 may contribute to unfavorable pregnancy outcomes. Results showed that pregnant women infected with SARS-CoV-2 had a higher risk of maternal death, fetal death/stillbirth, preterm birth, cesarean delivery, and cesarean section occurring before the onset of labor.
Cajachagua-Torres K, Xavier M, Quezada-Pinedo H, Huayanay-Espinoza C, Oviedo Rios A, Amouzou A J Glob Health. 2025; 15:04026.
PMID: 39885819 PMC: 11783137. DOI: 10.7189/jogh.15.04026.
Health system financing fragmentation and maternal mortality transition in Mexico, 2000-2022.
Servan-Mori E, Pineda-Antunez C, Cerecero-Garcia D, Flamand L, Mohar-Betancourt A, Millett C Int J Equity Health. 2025; 24(1):32.
PMID: 39881314 PMC: 11781072. DOI: 10.1186/s12939-024-02357-3.
Lira Neto J, Araujo M, Monteiro F, Freitas R, Teixeira C, Santos F Rev Esc Enferm USP. 2024; 58:e20230336.
PMID: 39584800 PMC: 11583968. DOI: 10.1590/1980-220X-REEUSP-2023-0336en.
Add-on hemoperfusion in SARS-CoV-2-infected pregnant patients: a case series.
Chiewroongroj S, Naorungroj T, Ratanarat R J Med Case Rep. 2024; 18(1):418.
PMID: 39223684 PMC: 11370091. DOI: 10.1186/s13256-024-04726-6.
Marcelino A, Pereira P, Charles C, Bahamondes L Sci Rep. 2024; 14(1):14982.
PMID: 38951554 PMC: 11217427. DOI: 10.1038/s41598-024-65946-w.